Cargando…
Simvastatin Evokes An Unpredicted Antagonism For Tamoxifen In MCF-7 Breast Cancer Cells
PURPOSE: Tamoxifen (TAM) is a non-steroidal antiestrogen drug, used in the prevention and treatment of all stages of hormone-responsive breast cancer. Simvastatin (SIM) is a lipid-lowering agent and has been shown to inhibit cancer cell growth. The study aimed to investigate the effect of the combin...
Autores principales: | Ibrahim, Amel B, Zaki, Hala F, Wadie, Walaa, Omran, Mervat M, Shouman, Samia A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886548/ https://www.ncbi.nlm.nih.gov/pubmed/31819634 http://dx.doi.org/10.2147/CMAR.S218668 |
Ejemplares similares
-
Evaluation of tamoxifen and simvastatin as the combination therapy for the treatment of hormonal dependent breast cancer cells
por: Ibrahim, Amel B., et al.
Publicado: (2019) -
Modulation of Tamoxifen Cytotoxicity by Caffeic Acid Phenethyl Ester in MCF-7 Breast Cancer Cells
por: Motawi, Tarek K., et al.
Publicado: (2016) -
Design, synthesis and biological evaluation of a new thieno[2,3-d]pyrimidine-based urea derivative with potential antitumor activity against tamoxifen sensitive and resistant breast cancer cell lines
por: Sharaky, Marwa, et al.
Publicado: (2020) -
Effects of Combined Pentadecanoic Acid and Tamoxifen Treatment on Tamoxifen Resistance in MCF−7/SC Breast Cancer Cells
por: To, Ngoc Bao, et al.
Publicado: (2022) -
Coffee decoction enhances tamoxifen proapoptotic activity on MCF-7 cells
por: Funakoshi-Tago, Megumi, et al.
Publicado: (2020)